Signalpoint

← Full daily brief

Health brief

Israeli Medtech Advances Target Bone Cancers, Amputations, and Mental Health Triage

Breakthrough 3D-printed pelvic implants, targeted antibiotic wound gels, and AI psychiatric intake platforms enter Israeli hospital care.

Signalpoint TeamBrief

Health

Custom 3D-printed bio-implants allow surgeons to remove massive pediatric bone tumors — offering limb-sparing options for cases previously considered untreatable worldwide.

BackgroundPelvic osteosarcoma resection in pediatric patients carries extreme surgical risk due to complex vascular and nerve anatomy. Custom 3D-printed bio-compatible implants allow surgeons to reconstruct complex skeletal structure and preserve limb function after removing massive malignancies.

Points
  1. The custom titanium and polymer implant was engineered for natural bone ingrowth, aiming to restore long-term patient mobility.
  2. The patient survived pediatric cancer at age 2 before undergoing targeted chemotherapy to shrink the tumor prior to surgery.
  3. The surgical team was led by orthopedic oncology specialists Dr. Arie Greenberg and Dr. Israel Weiss after months of 3D modeling.
SourcesThe Jerusalem Post: Israeli surgeons use custom 3D-printed implant to remove tumor deemed inoperable (opens in new tab)JNS: Clalit Innovation: Bone-cancer patient receives 3D-printed, half-pelvic implant in landmark surgery (opens in new tab)

Health

Direct local antibiotic gel delivery solves systemic blood flow barriers — significantly lowering amputation risks for high-stage diabetic foot ulcers.

BackgroundDiabetic foot ulcers and deep tissue infections remain a leading cause of non-traumatic lower extremity amputations worldwide. Systemic oral or intravenous antibiotics frequently fail because poor blood circulation prevents drugs from reaching deep necrotic tissue.

Points
  1. GentaGel delivers sustained local antibiotic doses directly into deep tissue wound sites for up to 60 days without systemic toxicity.
  2. The biodegradable gel clears antibiotic-resistant bacterial infections while promoting tissue regeneration, allowing severe chronic ulcers to close permanently.
  3. Led by CEO Dr. Ariel Orbach, the company is preparing expanded multicenter trials to support a future FDA regulatory pathway.
SourcesThe Jerusalem Post: GentaGel antibiotic gel saves diabetic foot from amputation (opens in new tab)Jewish Rhode Island: Targeted antibiotic gel helps 80% of pilot patients avoid foot amputation, Jerusalem trial finds (opens in new tab)

Health

Sheba is automating preliminary psychiatric intake with Ministry-approved AI — freeing overwhelmed mental health staff to focus on direct patient treatment.

BackgroundPost-war trauma and stress disorders have severely overloaded public mental health services across Israel. Ministry-approved digital intake tools automate initial clinical documentation so human staff can move acute patients into active therapy faster.

Points
  1. The system operates 24/7 using multilingual voice avatars to conduct structured intake interviews, eliminating human clinical documentation bottlenecks.
  2. Sheba psychiatric leadership emphasized that LIV automates preliminary clinical documentation without replacing human therapists or final physician diagnostic decisions.
  3. The deployment targets a 50% reduction in emergency department intake wait times, routing high-risk trauma patients directly to specialized psychiatric care.
SourcesSheba Medical Center ARC: LIV: Sheba's AI-Powered Clinical Support Tool (opens in new tab)

Unlock the full brief

Sign in to read every signal, takeaway, and source. Free account — Apple, Google, or email.

Or read free in the appDownload on the App Store